NOX5 and prostate carcinoma: The opposite result was observed for stem-like holoclones derived from the PC3 human prostate cancer cell line, which showed reduced expression of NOX2, NOX4, and NOX5, and their upregulation significantly lowered cell survival in vitro [139].